Evidence map›Paper›PMID 40084542›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2026

Household Transmission and Genomic Diversity of Respiratory Syncytial Virus in the United States, 2022-2023.

Sarah N Cox, Pavitra Roychoudhury, Collrane Frivold, Zack Acker, Tara M Babu, Cassandra L Boisvert, Marco Carone, Brenna Ehmen, Janet A Englund, Leora R Feldstein and 21 more

Abstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors.

Sarah N CoxDepartment of Medicine, University of Washington, Seattle, Washington, USA.ORCID 0000-0002-2447-0504
Pavitra RoychoudhuryDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA.ORCID 0000-0002-4567-8232
Collrane FrivoldDepartment of Medicine, University of Washington, Seattle, Washington, USA.ORCID 0000-0002-2000-5429
Zack AckerBrotman Baty Institute for Precision Medicine, Seattle, Washington, USA.
Tara M BabuDepartment of Medicine, University of Washington, Seattle, Washington, USA.ORCID 0000-0001-7093-4077
Cassandra L BoisvertKaiser Permanente Center for Health Research, Portland, Oregon, USA.
Marco CaroneDepartment of Biostatistics, University of Washington, Seattle, Washington, USA.
Brenna EhmenBrotman Baty Institute for Precision Medicine, Seattle, Washington, USA.
Janet A EnglundSeattle Children's Research Institute, Seattle, Washington, USA.ORCID 0000-0003-1134-4178
Leora R FeldsteinCoronavirus and Other Respiratory Viruses Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.ORCID 0000-0002-4430-6760
Luis GamboaBrotman Baty Institute for Precision Medicine, Seattle, Washington, USA.
Sally GrindstaffBrotman Baty Institute for Precision Medicine, Seattle, Washington, USA.
Hanna M GrioniSeattle Children's Research Institute, Seattle, Washington, USA.
Peter D HanBrotman Baty Institute for Precision Medicine, Seattle, Washington, USA.
Katherine L HoffmanDepartment of Biostatistics, University of Washington, Seattle, Washington, USA.
Hyeong Geon KimDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA.
Jennifer L KuntzKaiser Permanente Center for Health Research, Portland, Oregon, USA.ORCID 0000-0002-0017-6853
Natalie K LoDepartment of Medicine, University of Washington, Seattle, Washington, USA.
Christina M LockwoodDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA.ORCID 0000-0001-9036-7604
Kathryn McCaffreyBrotman Baty Institute for Precision Medicine, Seattle, Washington, USA.
Richard A MularskiKaiser Permanente Center for Health Research, Portland, Oregon, USA.
Tara L HatchieDepartment of Medicine, University of Washington, Seattle, Washington, USA.
Sacha L ReichKaiser Permanente Center for Health Research, Portland, Oregon, USA.
Mark A SchmidtKaiser Permanente Center for Health Research, Portland, Oregon, USA.ORCID 0000-0002-7440-7183
Ning SmithKaiser Permanente Center for Health Research, Portland, Oregon, USA.
Lea M StaritaBrotman Baty Institute for Precision Medicine, Seattle, Washington, USA.ORCID 0000-0003-2870-5099
Alexandra VargaKaiser Permanente Center for Health Research, Portland, Oregon, USA.ORCID 0000-0003-4735-4845
Neil YetzKaiser Permanente Center for Health Research, Portland, Oregon, USA.
Allison L NalewayKaiser Permanente Center for Health Research, Portland, Oregon, USA.
Ana A WeilDepartment of Medicine, University of Washington, Seattle, Washington, USA.ORCID 0000-0002-6170-4306
Helen Y ChuDepartment of Medicine, University of Washington, Seattle, Washington, USA.ORCID 0000-0001-8502-9600

Funding

CDC HHS 75D30121C12297
6 · The paper itself

Abstract

backgroundHousehold transmission of respiratory viruses may drive community spread. Few recent studies have examined household respiratory syncytial virus (RSV) transmission in the United States.

methodsWe conducted a prospective community-based cohort study from 1 June 2022 to 31 May 2023. Participants had blood samples collected and completed nasal swabs and surveys at least weekly, irrespective of symptoms. We tested serum for RSV antibody, nasal swabs by quantitative reverse transcription polymerase chain reaction (RT-qPCR), and performed whole genome sequencing. We evaluated secondary RSV transmission and associated risk factors based on a log-linear Poisson regression model.

resultsRSV was detected among 310 (10%) participants within 200 (20%) households. Most (94%) index cases were symptomatic. We identified 37 cases of potential secondary transmission within 14 days of a distinct index case (10%, 95% confidence interval [CI]: 7%, 14%); median age of index and secondary cases were 6 (interquartile range [IQR]: 3-10) and 35 (7-41) years, respectively, with 89% (24/27) of index cases aged 6 months to 12 years. Factors associated with increased risk of RSV transmission included index case viral detection ≥1 week and contact age ≤12 years. Of 120 sequenced specimens, the main lineages represented were A.d.5.2 (n = 37) and A.d.1 (n = 30). Sequenced viruses from households with ≥2 RSV infections were similar when occurring within ≤14 days (mean pairwise difference 4 [range 0-13], n = 17 households), compared to those >14 days (137 [37-236], n = 2).

conclusionsMost RSV household transmission occurs from infants and young children to adults. Viral genome sequencing demonstrated that multiple household infections within a 14-day period are likely due to within-household transmission.

Indexed as

Family CharacteristicsRespiratory Syncytial Virus, HumanRespiratory Syncytial Virus InfectionsAdolescentAdultAntibodies, ViralChildChild, PreschoolFemaleGenetic VariationGenome, ViralHumansInfantMaleMiddle AgedProspective StudiesAntibodies, Viralcommunity surveillancegenomicshousehold transmissionrespiratory syncytial virussecondary attack rate

Identifiers

PMID40084542
PMCPMC13613862

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.